Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
Which client is at greatest risk for osteoporosis?
A. A 30-year-old male who drinks alcohol occasionally with a BMI of 25
A 30-year-old male with occasional alcohol use and normal BMI (25) has minimal osteoporosis risk. Alcohol in moderation and normal weight do not significantly reduce bone density. Peak bone mass is typically preserved at this age, making him less at risk compared to glucocorticoid users.
B. A 22-year-old female who recently had a baby
A 22-year-old female post-pregnancy may experience temporary bone density loss due to calcium demands during pregnancy and lactation, but young age and ongoing bone remodeling reduce long-term osteoporosis risk. Recovery is likely with adequate nutrition, making her less at risk than the glucocorticoid-treated patient.
C. A 40-year-old male taking glucocorticoids for inflammatory bowel disease
Glucocorticoids, used for inflammatory bowel disease, significantly increase osteoporosis risk by inhibiting osteoblast activity, reducing calcium absorption, and increasing bone resorption. This 40-year-old male faces accelerated bone loss, especially with chronic use, making him the highest risk among the options due to medication-induced bone density reduction.
D. A 35-year-old female who recently began running marathons
A 35-year-old female running marathons engages in weight-bearing exercise, which promotes bone density through mechanical stress and osteoblast stimulation. This reduces osteoporosis risk compared to glucocorticoid use, as exercise enhances bone remodeling and strength, making her less likely to develop osteoporosis than the male on steroids.
This question is an excerpt from Nurse Dive's nursing test bank - Pathophamacology Proctored Exam (Examplify). Take the full exam now
Full Explanation
Choice A reason: A 30-year-old male with occasional alcohol use and normal BMI (25) has minimal osteoporosis risk. Alcohol in moderation and normal weight do not significantly reduce bone density. Peak bone mass is typically preserved at this age, making him less at risk compared to glucocorticoid users.
Choice B reason: A 22-year-old female post-pregnancy may experience temporary bone density loss due to calcium demands during pregnancy and lactation, but young age and ongoing bone remodeling reduce long-term osteoporosis risk. Recovery is likely with adequate nutrition, making her less at risk than the glucocorticoid-treated patient.
Choice C reason: Glucocorticoids, used for inflammatory bowel disease, significantly increase osteoporosis risk by inhibiting osteoblast activity, reducing calcium absorption, and increasing bone resorption. This 40-year-old male faces accelerated bone loss, especially with chronic use, making him the highest risk among the options due to medication-induced bone density reduction.
Choice D reason: A 35-year-old female running marathons engages in weight-bearing exercise, which promotes bone density through mechanical stress and osteoblast stimulation. This reduces osteoporosis risk compared to glucocorticoid use, as exercise enhances bone remodeling and strength, making her less likely to develop osteoporosis than the male on steroids.
Similar Questions
Which client presenting in the clinic most likely reveals manifestation(s) of rheumatoid arthritis?
A. A 35-year-old female with morning stiffness for 25 minutes in the knee
Morning stiffness lasting 25 minutes suggests mild joint inflammation but is not specific to rheumatoid arthritis (RA). RA typically involves stiffness exceeding 30-60 minutes and multiple joints bilaterally. This symptom alone is less indicative than red, spongy joints, making this choice less likely for RA.
B. A 45-year-old male with crepitus in the right knee
Crepitus in the right knee indicates cartilage wear, more characteristic of osteoarthritis than RA. RA causes synovial inflammation, not primarily crepitus. This 45-year-old male’s symptom suggests mechanical joint issues, not the inflammatory, systemic features of RA, making this choice incorrect.
C. A 30-year-old female with red, soft, spongy joints in both knees
Red, soft, spongy joints in both knees indicate synovial inflammation and effusion, hallmark signs of RA. This autoimmune disease causes bilateral joint swelling, warmth, and tenderness due to synovitis. This 30-year-old female’s symptoms align with RA’s clinical presentation, making this the most likely manifestation.
D. A 40-year-old male with osteophyte formation and decreased joint space in the left knee
Osteophyte formation and decreased joint space are typical of osteoarthritis, not RA. RA involves synovial inflammation and cartilage erosion without osteophytes early on. This 40-year-old male’s findings suggest degenerative joint disease, not the inflammatory changes of RA, making this choice incorrect.
Full Explanation
Choice A reason: Morning stiffness lasting 25 minutes suggests mild joint inflammation but is not specific to rheumatoid arthritis (RA). RA typically involves stiffness exceeding 30-60 minutes and multiple joints bilaterally. This symptom alone is less indicative than red, spongy joints, making this choice less likely for RA.
Choice B reason: Crepitus in the right knee indicates cartilage wear, more characteristic of osteoarthritis than RA. RA causes synovial inflammation, not primarily crepitus. This 45-year-old male’s symptom suggests mechanical joint issues, not the inflammatory, systemic features of RA, making this choice incorrect.
Choice C reason: Red, soft, spongy joints in both knees indicate synovial inflammation and effusion, hallmark signs of RA. This autoimmune disease causes bilateral joint swelling, warmth, and tenderness due to synovitis. This 30-year-old female’s symptoms align with RA’s clinical presentation, making this the most likely manifestation.
Choice D reason: Osteophyte formation and decreased joint space are typical of osteoarthritis, not RA. RA involves synovial inflammation and cartilage erosion without osteophytes early on. This 40-year-old male’s findings suggest degenerative joint disease, not the inflammatory changes of RA, making this choice incorrect.
The nurse is caring for a client who is diagnosed with an autoimmune disease that causes significant joint pain. The client reports that they take prednisone daily at home and occasionally take ibuprofen when the pain is extreme. What is the best response by the nurse?
A. Prednisone can exacerbate pain by increasing prostaglandin synthesis, so the provider may want to discontinue the prednisone
Prednisone reduces pain by inhibiting prostaglandin synthesis via phospholipase A2 suppression, not increasing it. Discontinuing prednisone may worsen autoimmune joint pain. This statement is inaccurate, as prednisone’s anti-inflammatory action is beneficial, and the issue lies in its combination with NSAIDs.
B. I will talk to the provider about having your prednisone switched to alternate day dosing so that your pain is better controlled
Alternate-day prednisone dosing reduces side effects but may not adequately control chronic autoimmune joint pain, as consistent suppression of inflammation is needed. This statement is less appropriate, as it does not address the primary concern of gastrointestinal risk from combining prednisone with ibuprofen.
C. Ibuprofen is not a very strong analgesic so if your pain is severe, the provider may want to start you on a prescription-strength ibuprofen
Ibuprofen is a potent NSAID, but its strength is not the issue. Combining it with prednisone increases gastrointestinal bleeding risk due to additive mucosal damage. Suggesting stronger ibuprofen is inappropriate and ignores the ulcer risk, making this statement inaccurate for safe pain management.
D. Taking steroids and NSAIDs can increase the risk for stomach ulcers so we need to discuss an alternate plan for pain management
Prednisone and NSAIDs like ibuprofen increase gastric ulcer risk by suppressing mucosal protective prostaglandins and increasing acid production. This combination can lead to bleeding or perforation, especially in autoimmune patients on chronic steroids. This statement is accurate, as it prioritizes discussing safer pain management alternatives.
Full Explanation
Choice A reason: Prednisone reduces pain by inhibiting prostaglandin synthesis via phospholipase A2 suppression, not increasing it. Discontinuing prednisone may worsen autoimmune joint pain. This statement is inaccurate, as prednisone’s anti-inflammatory action is beneficial, and the issue lies in its combination with NSAIDs.
Choice B reason: Alternate-day prednisone dosing reduces side effects but may not adequately control chronic autoimmune joint pain, as consistent suppression of inflammation is needed. This statement is less appropriate, as it does not address the primary concern of gastrointestinal risk from combining prednisone with ibuprofen.
Choice C reason: Ibuprofen is a potent NSAID, but its strength is not the issue. Combining it with prednisone increases gastrointestinal bleeding risk due to additive mucosal damage. Suggesting stronger ibuprofen is inappropriate and ignores the ulcer risk, making this statement inaccurate for safe pain management.
Choice D reason: Prednisone and NSAIDs like ibuprofen increase gastric ulcer risk by suppressing mucosal protective prostaglandins and increasing acid production. This combination can lead to bleeding or perforation, especially in autoimmune patients on chronic steroids. This statement is accurate, as it prioritizes discussing safer pain management alternatives.
Which client is at greatest risk of acute intra-renal kidney injury?
A. A 54-year-old male with bladder cancer
Bladder cancer primarily affects the bladder, causing hematuria or obstruction, leading to post-renal injury, not intra-renal. Intra-renal damage involves nephron injury, which is less likely with bladder cancer unless advanced metastasis affects kidneys, making this patient less at risk than one on nephrotoxic chemotherapy.
B. A 65-year-old male with benign prostatic hyperplasia
Benign prostatic hyperplasia causes urinary obstruction, leading to post-renal kidney injury from backpressure, not intra-renal damage. The kidneys’ nephrons are not directly harmed by BPH, making this 65-year-old male less at risk for intra-renal injury compared to a patient receiving nephrotoxic drugs.
C. A 25-year-old female receiving chemotherapy for cancer
Chemotherapy, especially agents like cisplatin, is nephrotoxic, causing intra-renal acute kidney injury by damaging renal tubules. This 25-year-old female faces high risk due to direct tubular toxicity, leading to acute tubular necrosis, making her the most likely to develop intra-renal injury among the options.
D. A 36-year-old female with renal artery stenosis
Renal artery stenosis causes pre-renal kidney injury by reducing renal perfusion, not intra-renal damage. The nephrons remain intact unless chronic ischemia leads to secondary damage. This 36-year-old female has a lower risk of intra-renal injury compared to the chemotherapy patient’s direct nephrotoxic exposure.
Full Explanation
Choice A reason: Bladder cancer primarily affects the bladder, causing hematuria or obstruction, leading to post-renal injury, not intra-renal. Intra-renal damage involves nephron injury, which is less likely with bladder cancer unless advanced metastasis affects kidneys, making this patient less at risk than one on nephrotoxic chemotherapy.
Choice B reason: Benign prostatic hyperplasia causes urinary obstruction, leading to post-renal kidney injury from backpressure, not intra-renal damage. The kidneys’ nephrons are not directly harmed by BPH, making this 65-year-old male less at risk for intra-renal injury compared to a patient receiving nephrotoxic drugs.
Choice C reason: Chemotherapy, especially agents like cisplatin, is nephrotoxic, causing intra-renal acute kidney injury by damaging renal tubules. This 25-year-old female faces high risk due to direct tubular toxicity, leading to acute tubular necrosis, making her the most likely to develop intra-renal injury among the options.
Choice D reason: Renal artery stenosis causes pre-renal kidney injury by reducing renal perfusion, not intra-renal damage. The nephrons remain intact unless chronic ischemia leads to secondary damage. This 36-year-old female has a lower risk of intra-renal injury compared to the chemotherapy patient’s direct nephrotoxic exposure.